Medical Treatment of Allergic Rhinitis
All around the Nose: Basic Science, Diseases and Surgical Management, Page: 311-317
2019
- 1Citations
- 35Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Most individuals with allergic rhinitis experience symptom improvement with pharmacologic management. Individuals with intermittent symptoms are usually handled effectively with oral decongestants, antihistamines, or a combination when necessary. Continuous use of a topical nasal steroid can be more appropriate for individuals with persistent symptoms. Nasal steroids may be used with, or instead of, regular consumption of a decongestant and/or an antihistamine. The more recent, second-generation non-sedating antihistamines avoid the drowsy side effects of the older, first-generation antihistamines. Eye drops and topical nasal sprays with antihistamine, anticholinergic medications, or cromolyn, as well as brief use of oral corticosteroids (for severe, acute attacks) can also alleviate allergic rhinitis symptoms. Steroids in general have a proven high level of efficacy. For the symptoms of allergic rhinitis, corticosteroids given intranasally are also highly efficacious. There is sometimes, however, a delay in the onset of the clinical effect. Regular usage is advisable. Every form of nonallergic rhinitis is amenable to treatment delivered intranasally. Leukotriene receptor antagonists are an alternative for treating allergic rhinitis. Pseudoephedrine given by mouth is a potent decongestant, which can be prescribed for prolonged periods. Nonetheless, the following side effects are reported: neurogenic symptoms, effects on the heart resulting in palpitations and sleep problems. Intranasal cromoglycate reportedly stabilises mast cell function and exerts an antiallergic effect by inhibiting mast cell degranulation. Cromoglycate does not in itself have an anti-inflammatory effect or cause blockade of histamine receptors. Cromoglycate is recommended as a prophylactic treatment. In this chapter, the medical treatment of allergic rhinitis is reviewed.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85091615034&origin=inward; http://dx.doi.org/10.1007/978-3-030-21217-9_35; http://link.springer.com/10.1007/978-3-030-21217-9_35; https://dx.doi.org/10.1007/978-3-030-21217-9_35; https://link.springer.com/chapter/10.1007/978-3-030-21217-9_35
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know